Bacitracin and/or daptomycin combined with cannabidiol for treatment of bacterial infections

Research output: PatentResearch

Abstract

The present invention relates to compositions comprising Cannabidiol (CBD) or pharmaceutically acceptable salts thereof, and bacitracin or pharmaceutically acceptable salts thereof and/or daptomycin or pharmaceutically acceptable salts thereof. The compositions show a synergistic effect in the inhibition of growth of Gram-positive bacteria. Thus, the compositions according to the invention may e.g. find use as medicaments in the treatment of Gram-positive bacterial infections.
Original languageEnglish
IPCA61K 31/352,A61K 45/06,A61K 38/12,A61P 31/04
Patent numberWO 2108/234301 A1
Filing date27/12/2018
CountryDenmark
Priority date19/06/2017
Priority numberEP20170176612
Publication statusPublished - 27. Dec 2018

Fingerprint

Daptomycin
Salts
Growth

Cite this

Klitgaard, J. K., & Wassmann, C. S. (2018). IPC No. A61K 31/352, A61K 45/06, A61K 38/12, A61P 31/04. Bacitracin and/or daptomycin combined with cannabidiol for treatment of bacterial infections. (Patent No. WO 2108/234301 A1).
@misc{91ab978ba6f44038b505d8176c3a3346,
title = "Bacitracin and/or daptomycin combined with cannabidiol for treatment of bacterial infections",
abstract = "The present invention relates to compositions comprising Cannabidiol (CBD) or pharmaceutically acceptable salts thereof, and bacitracin or pharmaceutically acceptable salts thereof and/or daptomycin or pharmaceutically acceptable salts thereof. The compositions show a synergistic effect in the inhibition of growth of Gram-positive bacteria. Thus, the compositions according to the invention may e.g. find use as medicaments in the treatment of Gram-positive bacterial infections.",
author = "Klitgaard, {Janne Kudsk} and Wassmann, {Claes S{\o}ndergaard}",
year = "2018",
month = "12",
day = "27",
language = "English",
type = "Patent",
note = "WO 2108/234301 A1; A61K 31/352,A61K 45/06,A61K 38/12,A61P 31/04",

}

Klitgaard, JK & Wassmann, CS Dec. 27 2018, Bacitracin and/or daptomycin combined with cannabidiol for treatment of bacterial infections, Patent No. WO 2108/234301 A1, IPC No. A61K 31/352, A61K 45/06, A61K 38/12, A61P 31/04.

Bacitracin and/or daptomycin combined with cannabidiol for treatment of bacterial infections. / Klitgaard, Janne Kudsk (Inventor); Wassmann, Claes Søndergaard (Inventor).

IPC No.: A61K 31/352, A61K 45/06, A61K 38/12, A61P 31/04. Patent No.: WO 2108/234301 A1. Dec 27, 2018.

Research output: PatentResearch

TY - PAT

T1 - Bacitracin and/or daptomycin combined with cannabidiol for treatment of bacterial infections

AU - Klitgaard, Janne Kudsk

AU - Wassmann, Claes Søndergaard

PY - 2018/12/27

Y1 - 2018/12/27

N2 - The present invention relates to compositions comprising Cannabidiol (CBD) or pharmaceutically acceptable salts thereof, and bacitracin or pharmaceutically acceptable salts thereof and/or daptomycin or pharmaceutically acceptable salts thereof. The compositions show a synergistic effect in the inhibition of growth of Gram-positive bacteria. Thus, the compositions according to the invention may e.g. find use as medicaments in the treatment of Gram-positive bacterial infections.

AB - The present invention relates to compositions comprising Cannabidiol (CBD) or pharmaceutically acceptable salts thereof, and bacitracin or pharmaceutically acceptable salts thereof and/or daptomycin or pharmaceutically acceptable salts thereof. The compositions show a synergistic effect in the inhibition of growth of Gram-positive bacteria. Thus, the compositions according to the invention may e.g. find use as medicaments in the treatment of Gram-positive bacterial infections.

UR - https://patentscope2.wipo.int/search/en/detail.jsf;jsessionid=FBC1DDFACED7ED5A8FC4816A8DBD7539?docId=WO2018234301&recNum=1874&office=&queryString=&prevFilter=%26fq%3DOF%3AWO&sortOption=Pub+Date+Desc&maxRec=3443385

M3 - Patent

M1 - WO 2108/234301 A1

Y2 - 2018/12/27

ER -